A biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that permits many tests to be performed at the same time in order to achieve higher throughput and speed. Typically, a biochip’s surface area is no larger than a fingernail.
Markets and Markets Recently Published the Report on Biochips Market Which Includes Following Points:
Increasing adoption of Personalized Medicine, growing Applications of Biochips, and Technological Advancements are the major drivers for the Biochips Market.
Based on Type, Market is segmented into DNA chips, Lab-on-a-chip, Protein chips, and other Arrays. The other arrays segment includes Cell arrays and Tissue arrays.
Get an Illustrative Overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=54
Based on Applications:
The DNA Chips Segment is categorized into gene expression, SNP genotyping, cancer diagnosis & treatment, genomics, agricultural biotechnology, drug discovery, and other applications (microbial genotyping, proteomics, toxicogenomics, screening and monitoring of patient data in clinical trials, and environmental biology).
The Lab-on-a-Chip Segment is classified into genomics, proteomics, drug discovery, IVD & POC clinical diagnostics, and other applications (biodefense, food pathogen identification, and environmental contamination).
The Protein Chips Segment is segmented into proteomics, high-throughput screening, drug discovery, and other applications (environmental diagnostics and biodefense).
Based on End Users, The Biochips Market is categorized into four major segments, namely, hospitals & diagnostic centers, biotechnology & pharmaceutical companies, academic & research institutes, and other end users
The key players in the Biochips Market are Agilent Technologies, Inc. (U.S.), PerkinElmer Inc. (U.S.), Fluidigm Corporation (U.S.), Illumina, Inc. (U.S.), GE Healthcare (U.S.), Bio-Rad Laboratories Inc. (U.S.), Cepheid Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).
Content Source: https://www.marketsandmarkets.com/PressReleases/biochips.asp